publication date: Sep. 19, 2014


html Funding.html

AACR Accepting Submissions to Two Dream Team Grants

THE AMERICAN ASSOCIATION FOR CANCER RESEARCH is accepting submissions of ideas to two dream team grants: one offering $20 million for lung cancer research, and one for $6 million for ovarian cancer research.

Funding for the lung cancer research grant will be provided by Stand Up To Cancer, the American Cancer Society and Bristol-Myers Squibb.

The research will be expected to involve new immunological approaches. Proposals for the grant must describe plans indicating how the group will use a transformative and synergistic approach, and how the work will be translated into the clinic. To maximize creativity, innovation, and collaboration, the projects should span multiple disciplines and use modern scientific tools to attack research questions in a coordinated effort.

A joint scientific advisory committee will evaluate applications in a multistep scientific review process. The committee is chaired by Nobel Laureate Phillip Sharp, institute professor at the David H. Koch Institute for Integrative Cancer Research at MIT. Arnold Levine, professor at the Institute for Advanced Study in Princeton, and at the Cancer Institute of New Jersey; and William Chambers, national vice president of extramural research at the American Cancer Society, will serve as vice-chairs.

Letters of Intent are due Nov. 5 via proposalCENTRAL.

The ovarian cancer research grant provides funding over three years, and is sponsored by Stand Up To Cancer, the Ovarian Cancer Research Fund, the Ovarian Cancer National Alliance, and the National Ovarian Cancer Coalition.

Proposals for the grant must describe plans indicating how the group will use a transformative and synergistic approach, and how the work will be translated into … Continue reading 40-35 Funding Opportunities

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.